Attenuated Vancomycin Bactericidal Activity against Staphylococcus aureus hemB Mutants Expressing the Small-Colony-Variant Phenotype
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The in vitro bactericidal activities of vancomycin against Staphylococcus aureus hemB mutants displaying the small-colony-variant phenotype and their parental strains were evaluated. Vancomycin killing activities against hemB mutants were markedly attenuated, demonstrating approximately 50% less effect, a result which was well described by a Hill-type pharmacodynamic model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to aminoglycoside resistance, SCVs that arise via the loss of the electron transport chain are more tolerant than wild-type bacteria of other classes of bactericidal antibiotics (8, 9, 25–29).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [29]
Citations
Cites
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836 · cited 1×
“Slow clinical responses, vancomycin’s slow bactericidal or bacteriostatic killing activity, and strains which display heterogeneous resistance to vancomycin severely limit its use for persistent infections (6, 9, 15).”
BackgroundSelf-citationVancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 759
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577 · cited 1×
“Slow clinical responses, vancomycin’s slow bactericidal or bacteriostatic killing activity, and strains which display heterogeneous resistance to vancomycin severely limit its use for persistent infections (6, 9, 15).”
BackgroundKahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357 · cited 1×
“These fastidious variants characterized by decreased pigment formation, reduced hemolytic activity, and decreased coagulase activity have been associated with chronic, relapsing, and persistent infections (8, 17, 18).”
Backgroundvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310 · cited 1×
“aureus SCVs may lie in their ability to persist intracellularly in nonprofessional phagocytes, thus evading surrounding host defenses and antimicrobial agents (4, 11, 23, 26).”
Backgroundvon Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Influence of a Functional sigB Operon on the Global Regulators sar and agr in Staphylococcus aureus
Bischoff, M., Entenza, J. M., & Giachino, P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.17.5171-5179.2001 · Cited by 235 · cited 1×
“Interestingly, it has been demonstrated previously that B reduces the levels of RNA III, the effector molecule of the agr system, in a growth phase-dependent manner (3, 20).”
BackgroundStaphylococcal Small Colony Variants Have Novel Mechanisms for Antibiotic Resistance
Proctor, R. A., Kahl, B., von Eiff, C., Vaudaux, P. E., Lew, D. P., & Peters, G. (1998) · Clinical Infectious Diseases · doi:10.1086/514906 · Cited by 204 · cited 2×
“aureus SCVs may lie in their ability to persist intracellularly in nonprofessional phagocytes, thus evading surrounding host defenses and antimicrobial agents (4, 11, 23, 26).”
Background
Research works printed but not linked: 1
- 10.3201/eid0910.0302000 · doi:10.3201/eid0910.0302000 · Paper page
Cited by
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
“The vancomycin killing activity was reduced in the SCV compared to the parental strain (359).”
BackgroundKahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
“activities compared to those for the parental isolates (195).”
BackgroundGao, W., Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes, N. E., Rhee, H.-W., Hong, J.-I., Hartland, E. L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000944 · Cited by 218
“[12], and reduced virulence [13].”
Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt072 · Cited by 177
Painter, K. L., Strange, E., Parkhill, J., Bamford, K. B., Armstrong-James, D., & Edwards, A. M. (2015) · Infection and Immunity · doi:10.1128/iai.03016-14 · Cited by 153
Metadata
- Authors
- Tsuji, B. T., von Eiff, C., Kelchlin, P. A., Forrest, A., & Smith, P. F.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- Institute of Medical Microbiology, University of Münster, Münster, Germany
- University at Buffalo, State University of New York (US)
- Corresponding author
- Tsuji, Brian T.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-04
- Volume
- 52
- Issue
- 4
- Pages
- 1533-1537
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2292514
- OpenAlex
- W2156669393
- Cited by
- 51
- References
- 29
- Citations by year
- 2026: 1 · 2025: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 8 · 2015: 5 · 2014: 1 · 2013: 6 · 2012: 4
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- vancomycin, Staphylococcus aureus, bactericidal activity, vancomycin resistance, folate biosynthesis
- MeSH terms
- Anti-Bacterial Agents, Hemin, Humans, Microbial Sensitivity Tests, Mutation, Phenotype, Staphylococcus aureus, Vancomycin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.